3 considerations for employment agencies during the public health and economic crisis

Authors: David Nelson & Andreas Gollner

How to make the most of disruption

Re-thinking their approaches during this time of change can help leaders in healthcare, life sciences and government to innovate and enable their organizations to emerge stronger than ever.

Integrating AI-powered clinical decision support into the EHR can help increase adoption and efficiency

Clinical decision support tools offer clinicians the ability to enhance the quality of care given to...

What patient-reported data can tell us about how to improve medication adherence

In a recent PULSE Health Poll, patients share why they do (and don’t) take prescriptions, which ...

Research reveals practice patterns in precision oncology

A new study of a cohort of Veterans Health Affairs (VHA) oncology patients illustrates complexity of clinician decision making around targeted therapies in a fast-moving field

Eliminating bias in health data science

It’s time for a renewed commitment to fairness, transparency and equity in data, big data and the algorithms for statistical or artificial intelligence (AI) models

Q&A: Interoperability and COVID-19, Part 2

Dr. Anil Jain describes how the pandemic’s disruption may affect the trajectory of sharing health information and considerations for those healthcare providers looking to invest.

A call for more complete race and ethnicity health data for COVID-19 response

Reported race and ethnicity health data is incomplete, with only 40 out of 50 states including this ...

Q&A: Interoperability and COVID-19, Part 1

How the pandemic response intersects with interoperability and requires healthcare providers to decide if they will defer or double-down on interoperability efforts.

How Long Will a Vaccine Really Take?

A vaccine would be the ultimate weapon against the coronavirus and the best route back to normal life.

The need to flatten the 4 curves of COVID-19

Responding to the pandemic requires us to “flatten the curve” that traces the physical impact of the disease. That's just the first curve. Additional curves are ascending for chronic disease management, mental health and economic health.

The search for life sciences solutions to the COVID-19 crisis

Helping to accelerate CROs that are working tirelessly and providing value to the clinical trial ...